Inactive Instrument

News Orchid Pharma Limited Bombay S.E.

Equities

524372

INE191A01019

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Orchid Pharma Gets Indian Regulator's Nod for Enmetazobactam	06-06	MT
Orchid Pharma Receives DCGI Approval for Its First Invented and Made-In-India Antibiotic Drug Combination of Cefepime and Enmetazobactam	06-06	CI
Transcript : Orchid Pharma Limited, Q4 2024 Earnings Call, May 24, 2024	05-24
Orchid Pharma Limited Appoints Shubha Singh as Additional Director	05-23	CI
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-23	CI
PUFE Transactions Under IBC	05-14	AQ
Orchid Pharma Limited Receives Order from Office of Assistant Commissioner Valluvarkottam Central-III Chennai Central	05-02	CI
Orchid Pharma Limited Announces Resignation of Mudit Tandon as Independent Director	04-12	CI
Orchid Pharma : Iii. Un-audited Financial Results for the quarter ended December 31, 2023 - Dec 31,2023	04-12	PU
Orchid Pharma : Un-audited Financial Results for the quarter ended June 30, 2023 - June 30,2023	04-12	PU
Orchid Pharma : Un-audited Financial Results for the quarter and half year ended September 30, 2023 - Sep 30,2023	04-12	PU
Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention	02-23	CI
Transcript : Orchid Pharma Limited, Q3 2024 Earnings Call, Feb 09, 2024	02-09
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-08	CI
European Medicines Agency Grants Approval for Orchid Pharma's 'Exblifep'	01-30	CI
Orchid Pharma Limited Appoints Kapil Dayya as Company Secretary & Compliance Officer	12-16	CI
Orchid Pharma Limited Announces Resignation of Marina Peter as Company Secretary and Compliance Officer	12-14	CI
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-04	CI
Orchid Pharma Limited Approves the Appointment of Mr. Arjun Dhanuka as Additional Director (In Capacity of Non-Executive & Non-Independent)	20/10/23	CI
Orchid Pharma Ties Up with GARDP to Manufacture Antibiotic for Certain Gram-Negative Infections	12/09/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Orchid Pharma Limited Bombay S.E.

Equities

524372

INE191A01019

Summary

Filters